keyboard_arrow_up

50% Off on Complete 2013-14 Induced Pluripotent Stem Cell Industry Report

Hurry, 50% for One Week Only on Complete 2013-14 Induced Pluripotent Stem Cell Industry Report - Offer Ends Friday, April 4th, 2014.

The burgeoning iPSC product market lures major industry competitors with double-digit growth and massive change in 2013.

Groundbreaking experimentation in 2006 led to the introduction of induced pluripotent stem cells (iPSCs). These are adult cells which are isolated and then transformed into embryonic-like stem cells through the manipulation of gene expression, as well as other methods. Research and experimentation using mouse cells at Kyoto University in Japan was the first instance in which there was a successful generation of induced pluripotent stem cells.  Then in 2007, a series of follow-up experiments done at Kyoto University successfully transformed human adult cells into iPSCs.

While there is widespread excitement regarding what these artificially re-manufactured cells can contribute to medical advances, there have also been issues, some of which have been prohibitive. By 2010, there were a number of private companies ready to capitalize on the breakthrough technology that iPSCs represent. One such company, Advanced Cell Technology in Worcester, Massachusetts, discovered problematic issues as they conducted experiments prior to applying for U.S. Food and Drug Administration approval for using induced pluripotent stem cells in therapeutic applications. Concerns such as premature cell death, mutation into cancer cells, and low proliferation rates were some of the problems that surfaced.

Stemming from both iPSC research advances and set-backs, a large and thriving products market has grown into existence.  The number of iPSC research products sold worldwide has been growing at an annual rate of 14.7% over the past five years. In addition, 22.1% of all stem cell researchers now self-report as having used induced pluripotent stem cells within a research project.  It is clear that iPSCs are a vital research trend within the scientific community.

Revealing new 2014 data, the "Complete 2013-14 Induced Pluripotent Stem Cell Industry Report" addresses these trends by strategically positioning research supply companies to expand, profit, and outmaneuver the competition. 

A distinctive feature of the report is the findings discovered as a result of surveying 274 researchers (131 U.S. / 143 International) that identify as having induced pluripotent stem cells as their core focus. This 2014 survey reveals iPSC researcher needs, technical preferences, key factors influencing buying decisions, and much more. They can be used to make effective product development decisions, create targeted marketing messages, and produce higher prospect-to-client conversion rates.

To benefit from this lucrative product market, you need to anticipate and serve the needs of your clients, or your competitors will.

Key Findings Include:

·         Charts, Timelines, and Financials for the iPSC Product Market

·         Trends for iPSC Grants, Scientific Publications, and Patents

·         5-Year Market Size Projections (2014-2018)

·         Competitive Environment Analysis, Including Market Share by Competitor

·         Preferred Species for iPSC Research

·         iPSC Product Categories (Breakdown of Market Share by Each)

·         Consumer Behavioral Patterns and Preferred Providers

·         Crucial Trends and Unmet Market Needs

·         “Tested" Language for Selling to iPSC Scientists

·         Breakdown of the Marketing Methods Used by Industry Participants

·         End-User Survey of iPSC Researchers (131 U.S. / 143 International)

Purchase Report @ http://www.reportsnreports.com/purchase.aspx?name=206575 - 50% for One Week Only Offer Ends on Friday, April 4th, 2014.

Table Of Contents
I. Abstract

II. iPSC cells Background
A. Definition
B. Discovery
C. Advantages & Disadvantages

III. Timeline
A. Production of iPSC cells (Key Events)
B. Full Timeline of Events

IV. iPSC cells Market Research Applications
A. Pharmaco-Toxicological Screening
B. Disease Modeling
C. Autologous Cell Transplantation
D. Breakdown of iPSC cells Research, By Applied Research Application

V. Characterization Of iPSC cells Research Advances
A. Methods of Making iPSC cells – Comparison of Methods by Downstream Application
B. Summary of iPSC cells Derivation Methods, by Cell Type
C. Diseases in Which iSPCs Have Been Derived from Patients

VI. Companies Selling iPSC cells Research Products
A. List of Companies
B. Rate of Entrants by Year

VII. Types Of Induced Pluripotent Stem Cells Research Products
A. Stem Cell Product Categories
B. iPSC cells Market Share Breakdown, By Product Area

VIII. Companies Developing iPSC cells Therapies
A. Commerical Entities
1. ViaCyte
2. Fate Therapeutic
3. iPerian
4. Cellular Dynamics
5. Mesoblast
B. Non-Commercial Organizations Developing iPSC cells Therapies

IX. Strategic Collaborations For Development Of Induced Pluripotent Stem Cells Products
A. Life Technologies
B. Lonza Group AG
C. EMD Millipore
D. Sigma Aldrich
E. Roslin Cells, Ltd.
F. ArunA Biomedical
G. CeeTox and Cellular Dynamics

X. iPSC cells Market Trend Analysis
A. Clinical Trials
B. Grant Analysis
1. Historical Analysis
2. Future 5-Year Projection
C. Patent Analysis
D. Scientific Publication Analysis
1. Historical Data
2. Future 5-Year Projections
3. Comparison of Induced Pluripotent Stem Cells Research Frequency, Relative to Other Cell Types
E. Search Phrase Analysis
1. Induced Pluripotent Stem Cell Search Terms
2. Induced Pluripotent Stem Cell “Google” Search Analysis
F. Geographical Analysis: Domestic vs. International Status
1. Number of iPSC cells Labs, by Region of World
2. Percent of Total iPSC cells -Specific Research Funding, by Region of World
G. Additional Sources of iPSC cells Research Funding

XI. Induced Pluripotent Stem Cells Market Size
A. Definition: iPSC cells Research Products
B. Experimental Approach
C. iPSC cells Research Products, Market Size
D. iPSC cells Research Products, 5-Year Market Projections

XII. Scientist Panel: Induced Pluripotent Stem Cells Detailed End-User Survey
A. Survey Overview
B. Characterization of Market Survey Respondents
1. Geographic Distribution of Respondents
2. Respondent Breakdown by Industry Affiliation
3. Breakdown of Respondents by Duration of iPSC cells Research Activity
C. Survey Findings
1. General Scope
2. Comparison of Providers / Brand Preferences
3. Marketing Assessment
D. Terms Used in Online Product Search

XIII. Strategies For Accessing The Marketplace
A. Top Research Institutions Performing Stem Cell Research
1. University of Wisconsin, including WARF, WiCell, and the WISC Bank
2. US National Institutes of Health (NIH)
3. Johns Hopkins University
4. California Institute for Regenerative Medicine
5. University of Connecticut Induced Pluripotent Stem Cells Core (iPSCC)
B. Events of Interest (2013-14)

XIV. Conclusions

About Us:

ReportsnReports.com is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details on sales@reportsandreports.com and we would be happy to help you find the business intelligence that you need. Not limited to the Stem Cell  ReportsnReports.com offers research studies on agriculture, consumer goods, environment, advanced materials, public sector, food and beverages, energy and power, medical devices, healthcare, automotive, manufacturing & construction, semiconductor and electronics, IT & telecommunication, pharmaceuticals, retail, water, banking and financial services , advanced materials and much more.